News
Zacks Investment Research on MSN23h
HAE Stock Gains on Q4 Earnings and Revenue Beat, Margins UpHaemonetics Corporation HAE delivered fourth-quarter fiscal 2025 adjusted earnings per share (EPS) of $1.24, which rose 37.8% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback